GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prestige Biologics Co Ltd (XKRX:334970) » Definitions » Days Sales Outstanding

Prestige Biologics Co (XKRX:334970) Days Sales Outstanding : 57.08 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Prestige Biologics Co Days Sales Outstanding?

Prestige Biologics Co's average Accounts Receivable for the three months ended in Mar. 2024 was ₩400 Mil. Prestige Biologics Co's Revenue for the three months ended in Mar. 2024 was ₩639 Mil. Hence, Prestige Biologics Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 57.08.

The historical rank and industry rank for Prestige Biologics Co's Days Sales Outstanding or its related term are showing as below:

XKRX:334970' s Days Sales Outstanding Range Over the Past 10 Years
Min: 31.98   Med: 365.98   Max: 27548.07
Current: 31.98

During the past 7 years, Prestige Biologics Co's highest Days Sales Outstanding was 27548.07. The lowest was 31.98. And the median was 365.98.

XKRX:334970's Days Sales Outstanding is ranked better than
84.56% of 881 companies
in the Biotechnology industry
Industry Median: 72.66 vs XKRX:334970: 31.98

Prestige Biologics Co's Days Sales Outstanding declined from Dec. 2022 (928.24) to Mar. 2024 (57.08).


Prestige Biologics Co Days Sales Outstanding Historical Data

The historical data trend for Prestige Biologics Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prestige Biologics Co Days Sales Outstanding Chart

Prestige Biologics Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Days Sales Outstanding
Get a 7-Day Free Trial - 365.98 - 132.89 27,548.07

Prestige Biologics Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 928.24 13.12 0.41 13.38 57.08

Competitive Comparison of Prestige Biologics Co's Days Sales Outstanding

For the Biotechnology subindustry, Prestige Biologics Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prestige Biologics Co's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Prestige Biologics Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Prestige Biologics Co's Days Sales Outstanding falls into.



Prestige Biologics Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Prestige Biologics Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

Days Sales Outstanding (A: Dec. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2021 ) + Accounts Receivable (A: Dec. 2022 )) / count ) / Revenue (A: Dec. 2022 )*Days in Period
=( (1174.831 + 0) / 1 ) / 15.566*365
=1174.831 / 15.566*365
=27,548.07

Prestige Biologics Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (219.598 + 579.674) / 2 ) / 638.829*365 / 4
=399.636 / 638.829*365 / 4
=57.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Prestige Biologics Co  (XKRX:334970) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Prestige Biologics Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Prestige Biologics Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Prestige Biologics Co (XKRX:334970) Business Description

Traded in Other Exchanges
N/A
Address
197, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Chungcheongbuk-do, Cheongju-si, KOR, 28161
Prestige Biologics Co Ltd is a CDMO-dedicated company that provides solutions of development and manufacturing tasks throughout the stages from the research/development, engineering, clinical production, commercial production, clinical support, and IND & BLA filing of biopharmaceutical products. Its product candidate includes HD201 (Herceptin Biosimilar).

Prestige Biologics Co (XKRX:334970) Headlines

No Headlines